Advanced search
1 file | 133.37 KB

Use of fecal calprotectin as marker of disease activity in patients under maintenance treatment with infliximab for ulcerative colitis

(2012) JOURNAL OF CROHNS & COLITIS. 6(suppl. 1). p.S4-S4
Author
Organization

Downloads

  • Use of fecal calprotectin as marker of disease activity in patients under maintenance treatment with infliximab for ulcerative colitis.pdf
    • full text
    • |
    • open access
    • |
    • PDF
    • |
    • 133.37 KB

Citation

Please use this url to cite or link to this publication:

Chicago
De Vos, Martine, J Jahnsen, J Vandervoort, G D’haens, O Dewit, E Louis, D Franchimont, et al. 2012. “Use of Fecal Calprotectin as Marker of Disease Activity in Patients Under Maintenance Treatment with Infliximab for Ulcerative Colitis.” In Journal of Crohns & Colitis, 6:S4–S4.
APA
De Vos, Martine, Jahnsen, J., Vandervoort, J., D’haens, G., Dewit, O., Louis, E., Franchimont, D., et al. (2012). Use of fecal calprotectin as marker of disease activity in patients under maintenance treatment with infliximab for ulcerative colitis. JOURNAL OF CROHNS & COLITIS (Vol. 6, pp. S4–S4). Presented at the 7th Congress of ECCO.
Vancouver
1.
De Vos M, Jahnsen J, Vandervoort J, D’haens G, Dewit O, Louis E, et al. Use of fecal calprotectin as marker of disease activity in patients under maintenance treatment with infliximab for ulcerative colitis. JOURNAL OF CROHNS & COLITIS. 2012. p. S4–S4.
MLA
De Vos, Martine, J Jahnsen, J Vandervoort, et al. “Use of Fecal Calprotectin as Marker of Disease Activity in Patients Under Maintenance Treatment with Infliximab for Ulcerative Colitis.” Journal of Crohns & Colitis. Vol. 6. 2012. S4–S4. Print.
@inproceedings{2047668,
  articleno    = {abstract OP07},
  author       = {De Vos, Martine and Jahnsen, J and Vandervoort, J and D'haens, G and Dewit, O and Louis, E and Franchimont, D and Baert, F and Torp, R and Potvin, P and Van Hootegem, P and Henriksen, M and Vander Cruyssen, Bert and Vermeire, S},
  booktitle    = {JOURNAL OF CROHNS \& COLITIS},
  issn         = {1873-9954},
  language     = {eng},
  location     = {Barcelona, Spain},
  number       = {suppl. 1},
  pages        = {abstract OP07:S4--abstract OP07:S4},
  title        = {Use of fecal calprotectin as marker of disease activity in patients under maintenance treatment with infliximab for ulcerative colitis},
  url          = {http://dx.doi.org/10.1016/S1873-9946(12)60008-7},
  volume       = {6},
  year         = {2012},
}

Altmetric
View in Altmetric